A new study led by researchers at UNSW Sydney’s Center for Healthy Brain Aging (CHeBA) has identified potential biological targets that could help guide future research into treatments for vascular dementia—a common and serious yet currently untreatable form of dementia.
This article was originally published on MedicalXpress.com

